Company Filing History:
Years Active: 2002-2003
Title: Béatrice Guagler: Innovator in Cancer Research
Introduction
Béatrice Guagler is a prominent inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly in the development of diagnostic methods and therapeutic applications. With a total of 3 patents, Guagler's work focuses on innovative approaches to understanding and treating cancer.
Latest Patents
One of Guagler's latest patents is titled "Methods for diagnosing a disorder by assaying for MAGE-3." This invention relates to nucleic acid molecules that code for the tumor rejection antigen precursor MAGE-3. The patent also discloses vectors, cell lines, and other materials that utilize the nucleic acid molecule, along with molecules coding for human leukocyte antigen HLA-A1. These materials have potential uses in both therapeutic and diagnostic contexts.
Another significant patent is "Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof." This patent describes isolated nucleic acid molecules that have complements hybridizing to a nucleic acid molecule referred to as MAGE-2. The isolated nucleic acid molecules are expressed in certain melanoma cells and other types of cancer cells. The invention also encompasses nucleic acid molecules that encode fragments of the proteins produced by these nucleic acid molecules, as well as those that encode the ultimate product, the tumor rejection antigens.
Career Highlights
Béatrice Guagler is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research in cancer diagnostics and therapeutics. His work has garnered attention for its potential impact on cancer treatment and patient outcomes.
Collaborations
Guagler has collaborated with notable colleagues in the field, including Pierre Van Den Bruggen and Thierry R Boon-Falleur. These collaborations have further enriched his research and contributed to the advancement of cancer therapies.
Conclusion
Béatrice Guagler is a key figure in cancer research, with a focus on innovative diagnostic methods and therapeutic applications. His contributions through patents and collaborations highlight his commitment to improving cancer treatment and understanding.